MONTREAL – MONTREAL (AP) _ Aeterna Zentaris Inc. (AEZS) on Monday reported a loss of $3.7 million in its first quarter.
On a per-share basis, the Montreal-based company said it had a loss of 37 cents.
The drug developer posted revenue of $242,000 in the period.
In the final minutes of trading on Monday, the company’s shares hit $3.48. A year ago, they were trading at $52.50.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at http://www.zacks.com/ap/AEZS
Keywords: Aeterna Zentaris, Earnings Report